ReviewSub-cellular biochemistry2026
Introduction to Carbonic Anhydrase.
Review in Sub-cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbonic anhydrases (CAs) form a widely distributed superfamily of metalloenzymes, characterized by considerable structural diversity. These enzymes catalyze the reversible conversion of carbon dioxide into bicarbonate and protons. While they all perform this fundamental reaction, CAs show notable structural plasticity, with eight classes (α, β, γ, δ, ζ, η, θ, and ι) that have evolved independently to optimize CO₂ hydration under a range of cellular, physiological, and ecological conditions. Their catalytic efficiency plays a crucial role in several biological processes, including acid-base balance, respiratory gas exchange, renal bicarbonate reabsorption, metabolic regulation, and photosynthetic carbon fixation. Isoform-specific expression allows CAs to act in multiple cellular contexts. They contribute to signaling pathways, help maintain pH balance, function within tissue-specific environments. When these enzymes are not properly regulated, they can be associated with a variety of health issues, including renal tubular acidosis, osteopetrosis, neurological disorders, and cancer progression. Evolution has shaped enzymes in different species to have similar active sites, flexible metal use, and varied protein assemblies, all helping them adapt to challenges like limited metal ions availability and changing CO₂ levels. CAs are not just important in biology. These metalloenzymes are also key targets for treating cancer, eye conditions, and infections. Besides, they show great promise as enzymes for capturing CO₂ and for other biotechnological applications. This chapter offers a thorough introduction to CAs, exploring their biology, how their structures and functions have evolved, and their potential applications, showing how these enzymes link the worlds of science, medicine, and the environment.
Indexed as
Identifiers
42062758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.